Highbury, Australia

Andrew Zannettino

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 104(Granted Patents)


Location History:

  • Adelaide, AU (2008 - 2012)
  • South Australia, AU (2015)
  • Highbury, AU (1998 - 2019)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew Zannettino

Introduction

Andrew Zannettino is a prominent inventor based in Highbury, Australia. He has made significant contributions to the field of medical research, particularly in cancer treatment and regenerative medicine. With a total of 12 patents to his name, Zannettino's work has the potential to impact various therapeutic approaches.

Latest Patents

One of Zannettino's latest patents is the Gremlin-1 antagonist for the prevention and treatment of cancer. This invention relates to an anti-GREM1 antagonist that can be utilized in methods for treating or preventing cancer. Another notable patent involves perivascular mesenchymal precursor cells. These cells have been isolated from perivascular niches across various tissues using a specific perivascular marker. The new mesenchymal precursor cell phenotype is characterized by the presence of the perivascular marker 3G5, along with alpha smooth muscle actin and early developmental markers such as MUC 18, VCAM-1, and STRO-1. This multipotential perivascular mesenchymal precursor cell is shown to form vascular tissue, as well as bone marrow, dentin, and pulp. Additionally, a method for enriching these cells using cell sorting based on the identified markers is described.

Career Highlights

Throughout his career, Zannettino has worked with notable companies such as Angioblast Systems, Inc. and Mesoblast, Inc. His innovative research and development efforts have positioned him as a key figure in the advancement of medical technologies.

Collaborations

Zannettino has collaborated with esteemed colleagues, including Stan Gronthos and Paul J Simmons. These partnerships have further enhanced his research capabilities and contributed to the success of his projects.

Conclusion

Andrew Zannettino's contributions to the field of medical research through his patents and collaborations highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to pave the way for advancements in cancer treatment and regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…